Riskpilot← Back to searchSign inGet full accessINTER LINE IMPORT/EXPORT ApS
APSActiveCVR 33050720Stillingvej 107Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20103 employeeswww.inter-line.dk
Revenue 2024
DKK 2,2M
+12% vs 2023
EBITDA margin
12.5%
-8% vs 2023
Equity ratio
44.1%
Financial strength
Net profit 2024
DKK 224K
+13% vs 2023
| Revenue | DKK 2,2M | +12% |
| EBITDA | DKK 281K | -8% |
| Net profit | DKK 224K | +13% |
| Total assets | DKK 1,7M | -21% |
| Equity | DKK 765K | -19% |
| Employees | 3 | — |
Legal name
INTER LINE IMPORT/EXPORT ApS
CVR number
33050720
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
30. juni 2010
Share capital
DKK 80.000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet skal ikke have nogen bestyrelse. Selskabet tegnes af direktøren. Tegningsreglen gælder i alle forhold, herunder køb og salg af fast ejendom.
Company purpose
Selskabets formål er import og videresalg (herunder eksport) af ortopædiske artikler til grossister for apoteker, bandagister samt hospitaler.
Address
Stillingvej 107
Phone
+4586985508
Email
Interline@mail.dk
Website
www.inter-line.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 782 | 853 | 1.060 | 1.294 | 947 | 987 | 1.119 | 1.312 | 1.373 | 1.882 | 1.679 | 2.012 | 2.250 |
| Staff expenses | -513 | -497 | -524 | -592 | -598 | -458 | -433 | -682 | -672 | -0 | -0 | -0 | -0 |
| EBITDA | 269 | 357 | 536 | 701 | 349 | 528 | 686 | 630 | 701 | 484 | 353 | 307 | 281 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 269 | 357 | 536 | 701 | 349 | 528 | 686 | 630 | 701 | 484 | 353 | 307 | 281 |
| Net financials | 10 | 15 | 4 | 1 | 2 | 17 | 22 | 28 | 26 | 49 | 15 | -54 | 9 |
| Profit before tax | 278 | 372 | 540 | 702 | 350 | 546 | 708 | 657 | 727 | 533 | 368 | 253 | 290 |
| Tax | 50 | 110 | 135 | 165 | 77 | 120 | 156 | 146 | 165 | 118 | 82 | 56 | 66 |
| Net profit | 229 | 262 | 405 | 537 | 273 | 425 | 551 | 512 | 562 | 415 | 287 | 197 | 224 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1.723 | 1.774 | 1.482 | 1.660 | 1.637 | 1.738 | 1.826 | 2.206 | 3.297 | 2.721 | 2.611 | 2.185 | 1.735 |
| Equity | 1.565 | 1.577 | 1.182 | 1.319 | 1.192 | 1.367 | 1.468 | 1.480 | 1.542 | 1.457 | 1.244 | 941 | 765 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 14 | 36 | 0 | 0 | 0 | 0 |
| Short-term debt | 157 | 197 | 299 | 340 | 445 | 371 | 358 | 712 | 1.719 | 1.264 | 1.368 | 1.244 | 970 |
| Total debt | 157 | 197 | 299 | 340 | 445 | 371 | 358 | 726 | 1.755 | 1.264 | 1.368 | 1.244 | 970 |
EBITDA margin
12.5%
This company
15.8%
Market median
-21% vs market
20122024
Equity ratio
44.1%
This company
38.2%
Market median
+15% vs market
20122024
Return on equity
29.3%
This company
18.4%
Market median
+59% vs market
20122024
Net profit margin
9.9%
This company
8.1%
Market median
+22% vs market
20122024
Asset turnover
1.30×
This company
1.12×
Market median
+16% vs market
20122024
Debt / equity
1.27×
This company
0.62×
Market median
-105% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Founder | Founder | 2010 | — | — |
Td Chief Executive Officer | Chief Executive Officer | 2016 | — | — |
MB Management | Management | 2010 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Fam. de Place Holding ApS | Company | 100.0% | 100.0% | 2016 |
INTER LINE HOLDING ApS | Company | 50.0% | 50.0% | 2011 |
MORTEN BUNDGAARD HOLDING ApS | Company | 50.0% | 50.0% | 2011 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Fam. de Place Holding ApS
INTER LINE IMPORT/EXPORT ApS Board members of INTER LINE IMPORT/EXPORT ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Morten Bundgaard | Founder | 0 companies |
| Torben de Place | Chief Executive Officer | 0 companies |
| Michael Bundgaard Mikkelsen | Management | 0 companies |